PharmaTher Holdings Income Statement

Financials in millions CAD. Fiscal year is June - May.

Millions CAD. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Nov '25 Nov 30, 2025	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021	2020
Selling, General & Admin	0.66	0.78	0.9	0.94	1.36	1.33	Upgrade
Research & Development	0.57	0.58	2.14	3.02	2.61	0.75	Upgrade
Operating Expenses	1.4	1.52	3.04	3.96	3.96	2.43	Upgrade
Operating Income	-1.4	-1.52	-3.04	-3.96	-3.96	-2.43	Upgrade
Interest & Investment Income	0.02	0.06	0.19	0.21	-	-	Upgrade
Earnings From Equity Investments	-0.04	-0.05	-0.05	-	-	-	Upgrade
Other Non Operating Income (Expenses)	-0.04	-0.05	-0.04	-0.03	-0.14	-0.39	Upgrade
EBT Excluding Unusual Items	-1.47	-1.56	-2.95	-3.78	-4.1	-2.82	Upgrade
Gain (Loss) on Sale of Investments	-	0.03	-0.17	-2.63	-0.13	-0.9	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-	7	Upgrade
Other Unusual Items	-	-	-	-	-	-0.39	Upgrade
Pretax Income	-1.47	-1.53	-3.12	-6.42	-4.24	2.89	Upgrade
Income Tax Expense	-	-	-	-	-0.23	0.23	Upgrade
Net Income	-1.47	-1.53	-3.12	-6.42	-4.01	2.66	Upgrade
Net Income to Common	-1.47	-1.53	-3.12	-6.42	-4.01	2.66	Upgrade
Shares Outstanding (Basic)	90	89	88	88	81	65	Upgrade
Shares Outstanding (Diluted)	90	89	88	88	81	73	Upgrade
Shares Change (YoY)	1.49%	0.33%	0.07%	8.71%	10.70%	114.98%	Upgrade
EPS (Basic)	-0.02	-0.02	-0.04	-0.07	-0.05	0.04	Upgrade
EPS (Diluted)	-0.02	-0.02	-0.04	-0.07	-0.05	0.04	Upgrade
Free Cash Flow	-1.03	-1.21	-3.52	-3.24	-3.51	0.92	Upgrade
Free Cash Flow Per Share	-0.01	-0.01	-0.04	-0.04	-0.04	0.01	Upgrade
EBITDA	-	-1.52	-3.04	-3.96	-3.96	-2.43	Upgrade
D&A For EBITDA	-	0	0	0	0	0	Upgrade
EBIT	-1.4	-1.52	-3.04	-3.96	-3.96	-2.43	Upgrade
Effective Tax Rate	-	-	-	-	-	7.79%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.